BioTelemetry (BEAT) Misses Q3 EPS by 9c

BioTelemetry (NASDAQ: BEAT) reported Q3 EPS of $0.16, $0.09 worse than the analyst estimate of $0.25. Revenue for the quarter came in at $81 million versus the consensus estimate of $82.62 million.

For earnings history and earnings-related data on BioTelemetry (BEAT) click here.

You May Also Be Interested In

• Academy Sports and Outdoor (ASO) Tops Q2 EPS by 22c, Offers Guidance
• Signet shares jump on Q2 profit beat, raised annual guidance
• Korn Ferry (KFY) Tops Q1 EPS by 7c, Beats on Revenue; Offers Q2 EPS Guidance